Ovintiv (NYSE:OVV) Research Coverage Started at Barclays
Research analysts at Barclays started coverage on shares of Ovintiv (NYSE:OVV – Get Free Report) in a research report issued to clients and investors on Wednesday, MarketBeat reports. The brokerage set an “overweight” rating and a $69.00 price target on the stock. Barclays‘s target price points to a potential upside of 25.77% from the company’s […]
More Stories
Rep. Lisa C. McClain Purchases Shares of Oracle Corporation (NYSE:ORCL)
Representative Lisa C. McClain (R-Michigan) recently bought shares of Oracle Corporation (NYSE:ORCL). In a filing disclosed on August 13th, the...
What is Zacks Research’s Estimate for NOV Q1 Earnings?
NOV Inc. (NYSE:NOV – Free Report) – Stock analysts at Zacks Research upped their Q1 2027 earnings estimates for NOV...
Zacks Research Issues Negative Forecast for HII Earnings
Huntington Ingalls Industries, Inc. (NYSE:HII – Free Report) – Investment analysts at Zacks Research dropped their Q3 2026 EPS estimates...
HC Wainwright Issues Pessimistic Estimate for ABEO Earnings
Abeona Therapeutics Inc. (NASDAQ:ABEO – Free Report) – Investment analysts at HC Wainwright lowered their Q1 2026 earnings per share...
TSE:CHE FY2026 EPS Boosted by National Bank Financial
Chemtrade Logistics Income Fund (TSE:CHE – Free Report) – Research analysts at National Bank Financial upped their FY2026 earnings per...
Research Analysts Offer Predictions for ATS Q3 Earnings
ATS Co. (TSE:ATS – Free Report) – Raymond James Financial dropped their Q3 2026 earnings per share (EPS) estimates for...